Edwards Lifesciences ROA 2010-2024 | EW

Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Edwards Lifesciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $4.16B $12.97B 39.45%
2024-06-30 $1.47B $10.10B 15.28%
2024-03-31 $1.41B $9.74B 15.09%
2023-12-31 $1.40B $9.36B 15.42%
2023-09-30 $1.43B $9.37B 16.21%
2023-06-30 $1.39B $9.00B 16.08%
2023-03-31 $1.49B $8.65B 17.51%
2022-12-31 $1.52B $8.29B 18.02%
2022-09-30 $1.46B $8.64B 17.17%
2022-06-30 $1.46B $8.43B 17.37%
2022-03-31 $1.54B $8.42B 18.80%
2021-12-31 $1.50B $8.50B 19.06%
2021-09-30 $1.48B $8.16B 19.53%
2021-06-30 $1.46B $7.66B 20.24%
2021-03-31 $0.85B $7.21B 12.30%
2020-12-31 $0.82B $7.24B 12.42%
2020-09-30 $0.79B $6.80B 12.32%
2020-06-30 $0.74B $6.42B 11.93%
2020-03-31 $1.11B $6.08B 18.39%
2019-12-31 $1.05B $6.49B 17.82%
2019-09-30 $0.77B $5.97B 13.86%
2019-06-30 $0.73B $5.57B 12.99%
2019-03-31 $0.77B $5.47B 13.66%
2018-12-31 $0.72B $5.32B 12.69%
2018-09-30 $0.71B $5.96B 12.33%
2018-06-30 $0.66B $5.69B 11.59%
2018-03-31 $0.56B $5.83B 10.13%
2017-12-31 $0.58B $5.67B 11.07%
2017-09-30 $0.75B $5.49B 14.96%
2017-06-30 $0.72B $5.14B 15.26%
2017-03-31 $0.66B $4.78B 14.86%
2016-12-31 $0.57B $4.51B 13.61%
2016-09-30 $0.55B $4.34B 13.55%
2016-06-30 $0.53B $4.05B 13.36%
2016-03-31 $0.52B $3.85B 13.38%
2015-12-31 $0.50B $4.06B 13.17%
2015-09-30 $0.46B $3.88B 12.78%
2015-06-30 $0.44B $3.61B 12.60%
2015-03-31 $0.87B $3.49B 25.54%
2014-12-31 $0.81B $3.52B 25.24%
2014-09-30 $0.78B $3.35B 25.82%
2014-06-30 $0.76B $3.33B 27.06%
2014-03-31 $0.31B $2.65B 11.92%
2013-12-31 $0.39B $2.71B 15.75%
2013-09-30 $0.40B $2.53B 17.17%
2013-06-30 $0.40B $2.34B 17.45%
2013-03-31 $0.37B $2.30B 16.84%
2012-12-31 $0.29B $2.22B 13.70%
2012-09-30 $0.27B $2.20B 12.84%
2012-06-30 $0.25B $2.08B 12.33%
2012-03-31 $0.24B $2.00B 11.94%
2011-12-31 $0.24B $1.98B 12.00%
2011-09-30 $0.24B $1.98B 12.44%
2011-06-30 $0.24B $2.00B 12.66%
2011-03-31 $0.24B $1.93B 13.31%
2010-12-31 $0.22B $1.77B 13.00%
2010-09-30 $0.20B $1.73B 12.27%
2010-06-30 $0.23B $1.64B 14.11%
2010-03-31 $0.22B $1.60B 13.87%
2009-12-31 $0.23B $1.62B 15.29%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $43.628B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $200.813B 24.50
Intuitive Surgical (ISRG) United States $194.018B 101.44
Alcon (ALC) Switzerland $42.291B 28.30
IQVIA Holdings (IQV) United States $36.367B 20.04
IDEXX Laboratories (IDXX) United States $35.798B 42.16
DexCom (DXCM) United States $30.830B 46.43
Waters (WAT) United States $22.743B 33.63
STERIS (STE) Ireland $21.361B 24.59
SONOVA HOLDING (SONVY) Switzerland $19.498B 0.00
Hologic (HOLX) United States $17.041B 18.40
Fresenius Medical Care AG KGaA (FMS) Germany $13.902B 14.27
Sysmex ADR (SSMXY) Japan $12.298B 38.57
Globus Medical (GMED) United States $11.262B 28.52
Penumbra (PEN) United States $9.682B 94.83
Masimo (MASI) United States $9.374B 45.36
Teleflex (TFX) United States $8.514B 13.58
Glaukos (GKOS) United States $7.737B 0.00
PROCEPT BioRobotics (PRCT) United States $4.687B 0.00
Integer Holdings (ITGR) United States $4.672B 26.48
Veracyte (VCYT) United States $3.441B 103.26
Inari Medical (NARI) United States $3.299B 0.00
LivaNova (LIVN) United Kingdom $2.830B 16.33
Nihon Kohden (NHNKY) Japan $2.541B 19.30
Tandem Diabetes Care (TNDM) United States $2.253B 0.00
TransMedics (TMDX) United States $2.205B 69.90
Elekta AB (EKTAY) Sweden $2.177B 19.57
Integra LifeSciences Holdings (IART) United States $1.870B 9.77
RxSight (RXST) United States $1.447B 0.00
Alphatec Holdings (ATEC) United States $1.376B 0.00
Artivion (AORT) United States $1.237B 81.94
OPKO Health (OPK) United States $1.099B 0.00
Pulse Biosciences (PLSE) United States $1.054B 0.00
Paragon 28 (FNA) United States $0.856B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.847B 14.41
ORTHOFIX MEDICAL INC (OFIX) United States $0.691B 0.00
Mesa Laboratories (MLAB) United States $0.691B 16.28
IRadimed (IRMD) United States $0.690B 37.28
AxoGen (AXGN) United States $0.634B 0.00
Semler Scientific (SMLR) United States $0.595B 35.04
SiBone (SIBN) United States $0.571B 0.00
Pacific Biosciences Of California (PACB) United States $0.560B 0.00
OrthoPediatrics (KIDS) United States $0.531B 0.00
Treace Medical Concepts (TMCI) United States $0.475B 0.00
ClearPoint Neuro (CLPT) United States $0.452B 0.00
Tactile Systems Technology (TCMD) United States $0.435B 23.55
Delcath Systems (DCTH) United States $0.377B 0.00
AngioDynamics (ANGO) United States $0.373B 0.00
NeuroPace (NPCE) United States $0.326B 0.00
CVRx (CVRX) United States $0.325B 0.00
Inogen (INGN) United States $0.221B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
KORU Medical Systems (KRMD) United States $0.202B 0.00
Accuray (ARAY) United States $0.193B 0.00
Sight Sciences (SGHT) United States $0.189B 0.00
Nevro (NVRO) United States $0.158B 0.00
Atossa Genetics (ATOS) United States $0.145B 0.00
Sensus Healthcare (SRTS) United States $0.139B 14.90
Spectral Diagnostics (EDTXF) Canada $0.104B 0.00
LENSAR (LNSR) United States $0.090B 0.00
Monogram Orthopaedics (MGRM) United States $0.088B 0.00
Vicarious Surgical (RBOT) United States $0.088B 0.00
EDAP TMS S.A (EDAP) France $0.082B 0.00
InspireMD (NSPR) Israel $0.081B 0.00
908 Devices (MASS) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
WORK Medical Technology Group (WOK) China $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.050B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.044B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Spectral AI (MDAI) United States $0.038B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Accelerate Diagnostics (AXDX) United States $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Adagio Medical Holdings (ADGM) United States $0.031B 0.00
NexGel (NXGL) United States $0.030B 0.00
Biosig Technologies (BSGM) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
Baird Medical Investment Holdings (BDMD) $0.010B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
PAVmed (PAVM) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00